FN1 and neoplasm: FN1, as a core ECM component secreted by scPAS + cells, enhances scPAS + cell-vascular wall anchoring through “endothelial cell-tumor cell” adhesion bridge construction, reducing tumor cell detachment and apoptosis following TACE treatment.